TY - JOUR
T1 - Anxiety and Depression Symptoms in COVID-19 Isolated Patients and in Their Relatives
AU - Dorman-Ilan, Shirel
AU - Hertz-Palmor, Nimrod
AU - Brand-Gothelf, Ayelet
AU - Hasson-Ohayon, Ilanit
AU - Matalon, Noam
AU - Gross, Raz
AU - Chen, Wendy
AU - Abramovich, Ayelet
AU - Afek, Arnon
AU - Ziv, Amitai
AU - Kreiss, Yitshak
AU - Pessach, Itai M.
AU - Gothelf, Doron
N1 - Publisher Copyright: © Copyright © 2020 Dorman-Ilan, Hertz-Palmor, Brand-Gothelf, Hasson-Ohayon, Matalon, Gross, Chen, Abramovich, Afek, Ziv, Kreiss, Pessach and Gothelf.
PY - 2020/10/14
Y1 - 2020/10/14
N2 - Background: While focusing on the management and care of COVID-19 patients, the mental health of these patients and their relatives is being overlooked. The aim of the current study was to measure anxiety and depression, and to assess their association with socio-demographic and pandemic-related stress factors in COVID-19 patients and their relatives during the initial stage of hospitalization. Methods: We assessed isolated hospitalized patients (N = 90) and their relatives (adults and children, N = 125) by phone, 25–72 h following patients' admission. The quantitative measures included the Anxiety and Depression modules of the Patient-Reported Outcomes Measurement Information System (PROMIS) and pandemic-related stress factors. Qualitative measures included questions exploring worries, sadness, and coping modes. Results: Both patients and relatives suffer from high levels of anxiety and related pandemic worries, with lower levels of depressive symptoms. Compared to adult relatives, child relatives reported significantly lower anxiety. The multivariable logistic regression analysis revealed an increased risk for anxiety among females and a decreased risk among ultra-orthodox participants. While increased anxiety among patients was associated with feelings of isolation, increased anxiety among relatives was associated with a feeling of not being protected by the hospital. Conclusions: Patients and relatives experience similar high anxiety levels which are more robust in women and lower in ultra-orthodox participants. Our findings indicate that anxiety symptoms of both patients and adult relatives should be addressed.
AB - Background: While focusing on the management and care of COVID-19 patients, the mental health of these patients and their relatives is being overlooked. The aim of the current study was to measure anxiety and depression, and to assess their association with socio-demographic and pandemic-related stress factors in COVID-19 patients and their relatives during the initial stage of hospitalization. Methods: We assessed isolated hospitalized patients (N = 90) and their relatives (adults and children, N = 125) by phone, 25–72 h following patients' admission. The quantitative measures included the Anxiety and Depression modules of the Patient-Reported Outcomes Measurement Information System (PROMIS) and pandemic-related stress factors. Qualitative measures included questions exploring worries, sadness, and coping modes. Results: Both patients and relatives suffer from high levels of anxiety and related pandemic worries, with lower levels of depressive symptoms. Compared to adult relatives, child relatives reported significantly lower anxiety. The multivariable logistic regression analysis revealed an increased risk for anxiety among females and a decreased risk among ultra-orthodox participants. While increased anxiety among patients was associated with feelings of isolation, increased anxiety among relatives was associated with a feeling of not being protected by the hospital. Conclusions: Patients and relatives experience similar high anxiety levels which are more robust in women and lower in ultra-orthodox participants. Our findings indicate that anxiety symptoms of both patients and adult relatives should be addressed.
KW - COVID-19
KW - anxiety
KW - children
KW - depression
KW - patients
KW - relatives
UR - http://www.scopus.com/inward/record.url?scp=85094650185&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2020.581598
DO - 10.3389/fpsyt.2020.581598
M3 - Article
C2 - 33192727
SN - 1664-0640
VL - 11
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 581598
ER -